Citation Impact
Citing Papers
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
A small-molecule switch for Golgi sulfotransferases
2004 StandoutNobel
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Eradication of Multi-drug Resistant Acinetobacter from an Intensive Care Unit
2001
Emergence of Nosocomial Candidemia at a Teaching Hospital in Taiwan from 1981 to 2000: Increased Susceptibility of Candida Species to Fluconazole
2002
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
2003
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
2017
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
2004
Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease
2015
Candida Colonization and Candiduria in Critically Ill Patients in the Intensive Care Unit
2009
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand
2007
Changes of microbial flora and wound colonization in burned patients
2004
Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies
2008
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
2002 Standout
The need for new antibiotics
2004
Host defense peptides in burns
2004
Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia
2002
Comparison of Ampicillin‐Sulbactam and Imipenem‐Cilastatin for the Treatment ofAcinetobacterVentilator‐Associated Pneumonia
2002
Prevalence of Low Glomerular Filtration Rate in Nondiabetic Americans
2002
In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii
2006
Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina
2005
Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005
2006
Antimicrobial resistance among non-fermentative Gram-negative bacilli isolated from the respiratory tracts of Italian inpatients: a 3-year surveillance study by the Italian Epidemiological Survey
2004
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program
2004
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B
2005
Trends in Antimicrobial Drug Development: Implications for the Future
2004
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
Prevalence of Kidney Damage in Australian Adults
2003
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units
2006
Outcomes of Acinetobacter baumannii Infection in Critically Ill Burned Patients
2007
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999–2003)
2004
Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii
2004
Activities of various β-lactams and β-lactam/β-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains
2005
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
2006
Risk Factors forAcinetobacter baumanniiNosocomial Bacteremia in Critically Ill Patients: A Cohort Study
2001
Estimation of Glomerular Filtration Rate in Older Patients with Chronic Renal Insufficiency: Is the Modification of Diet in Renal Disease Formula an Improvement?
2003
Subclinical Atherosclerotic Changes Related to Chronic Kidney Disease in Asymptomatic Black and White Young Adults: The Bogalusa Heart Study
2011
Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC Study
2003
Molecular and Structural Characterization of the HMP-AB Gene Encoding a Pore-Forming Protein from a Clinical Isolate of Acinetobacter baumannii
2003
Systematic review and meta-analysis of antibiotic therapy for bone and joint infections
2001
Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU
2006
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
2007
Integrons as tools for epidemiological studies
2004
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
2006
Emergence of Carbapenem Resistance inAcinetobacter baumanniiRecovered From Blood Cultures in Australia
2006
Post-Neurosurgical Meningitis Due to Multidrug-ResistantAcinetobacter baumaniiTreated with Intrathecal Colistin: Case Report and Review of the Literature
2006
Changes in α(1–2)-Fucosyltransferase Activity in the Murine Endometrial Epithelium during the Estrous Cycle, Early Pregnancy, and after Ovariectomy and Hormone Replacement1
1994
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria
2006
The threat from the pink corner
2003
Endemic Carbapenem-Resistant Acinetobacter Species in Brooklyn, New York: Citywide Prevalence, Interinstitutional Spread, and Relation to Antibiotic Usage
2000
AcinetobacterOutbreaks, 1977–2000
2003
Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital
2007
Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas
2003
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
2005
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection
2005
Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii Meningitis
2002
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
The Science of Antibiotic Discovery
2020 Standout
Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital
2003
Catheter-Associated Bloodstream Infections in General Medical Patients Outside the Intensive Care Unit: A Surveillance Study
2007
International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents
1999
OXA-type carbapenemases
2006
Isoprenyl diphosphate synthases
2000
Novel Antibiotic Combinations against Infections with Almost Completely Resistant Pseudomonas aeruginosa and Acinetobacter Species
2006
Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI 21 and Cecropin P1
2001
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
2006
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
2005
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
2006 Standout
Metabolic Delivery of Ketone Groups to Sialic Acid Residues
1998 StandoutNobel
Risk Factors for Nosocomial Bloodstream Infections Due to Acinetobacter baumannii: A Case‐Control Study of Adult Burn Patients
1999
Dissemination of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital
2008
In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii
2005
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
2005
Characterization ofPseudomonas aeruginosaIsolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999
2001
High rate of non-albicans candidemia in Brazilian tertiary care hospitals
1999 Standout
Candida Urinary Tract Infections—Epidemiology
2011
Concurrent Outbreak of Multidrug-Resistant and Susceptible Subclones of Acinetobacter baumannii Affecting Different Wards of a Single Hospital
2005
Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii
2006
Detection of Chronic Kidney Disease With Laboratory Reporting of Estimated Glomerular Filtration Rate and an Educational Program
2004
Infections in Patients with Diabetes Mellitus
1999 Standout
Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility
2000
In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain
2004
Microbiological Activity and Clinical Efficacy of a Colistin and Rifampin Combination in Multidrug-ResistantPseudomonas aeruginosaInfections
2004
Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment
2003
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
2004
Has the era of untreatable infections arrived?
2009
Sulbactam-containing β-lactamase inhibitor combinations
2008
Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences
2007
Vertebral Osteomyelitis
2010 Standout
A population-based study of the incidence and outcomes of diagnosed chronic kidney disease
2003
Antimicrobial resistance of Acinetobacter spp. in Europe
2004
Microsatellite multilocus genotyping clarifies the relationship of Candida parapsilosis strains involved in a neonatal intensive care unit outbreak
2011
High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii
2007
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
2004
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY
2007
Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa
2005
Siccanin Rediscovered as a Species-Selective Succinate Dehydrogenase Inhibitor
2009 StandoutNobel
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Intravenous Colistin for the Treatment of Multi-Drug Resistant, Gram-Negative Infection in the Pediatric Burn Population
2007
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
2004
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)
2006
Candidemia by Species of the Candida parapsilosis Complex in Children’s Hospital: Prevalence, Biofilm Production and Antifungal Susceptibility
2013
Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
2003
A Novel Antibacterial Gene Transfer Treatment for Multidrug-Resistant Acinetobacter Baumannii-Induced Burn Sepsis
2007
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome
2006
Herpes Zoster
2013 Standout
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
2008
CKD and Health-Related Quality of Life: The Korea National Health and Nutrition Examination Survey
2015
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
β-Lactamase inhibitors: evolving compounds for evolving resistance targets
2004
Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia
2006
Successful Treatment of Multidrug-Resistant Acinetobacter baumannii Meningitis with Intravenous Colistin Sulfomethate Sodium
2000
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumannii
2003
Antimicrobial resistance among gram-negative organisms in the intensive care unit
2003
Dissemination of IMP-1 Metallo-β-Lactamase–Producing Acinetobacter Species in a Brazilian Teaching Hospital
2006
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia
2003
Polymyxin B Identified as an Inhibitor of Alternative NADH Dehydrogenase and Malate: Quinone Oxidoreductase from the Gram-positive Bacterium Mycobacterium smegmatis
2009 StandoutNobel
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin
2006
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Increasing Incidence of Sterile-Site Infections Due to Non-Multidrug-Resistant, Oxacillin-Resistant Staphylococcus aureus Among Hospitalized Patients
2007
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study
2005
Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
2006
The Pharmacokinetics of Colistin in Patients with Cystic Fibrosis
2001
Treatment of Nosocomial Pneumonia and Tracheobronchitis Caused by Multidrug-Resistant Pseudomonas aeruginosa with Aerosolized Colistin
2000
Interventions to improve hand hygiene compliance in patient care
2017 Standout
Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults
2015
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Studies on the Biosynthesis of Cholesterol
1966 StandoutNobel
A New Intermediate in the Biosynthesis of Squalene
1966
The Biological Synthesis of Cholesterol
1965 Science
Antibiotic resistance is ancient
2011 StandoutNature
In Vitro Activities of the β-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with β-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains
2004
Reliability of the E-Test Method for Detection of Colistin Resistance in Clinical Isolates of Acinetobacter baumannii
2005
Multicenter Studies of Tigecycline Disk Diffusion Susceptibility Results for Acinetobacter spp
2006
Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.
2002
Surveillance Cultures and Duration of Carriage of Multidrug-Resistant Acinetobacter baumannii
2007
Chemical Glycobiology
2001 StandoutScienceNobel
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design
2009
Candida parapsilosisCharacterization in an Outbreak Setting
2004
Cloning and Functional Analysis of the Gene Encoding the 33- to 36-Kilodalton Outer Membrane Protein Associated with Carbapenem Resistance in Acinetobacter baumannii
2005
Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1–bla OXA-23 genes in a Chinese hospital
2007
Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003
2006
Identification of an OprD Homologue in Acinetobacter baumannii
2005
Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration
2003
Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol.
1967
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Nosocomial Acinetobacter baumannii Infections: Microbiological and Clinical Epidemiology
1998
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii
2001
Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998
2000
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
2006
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Removal of the 4,4-Dimethyl Carbons in the Enzymic Conversion of Lanosterol to Cholesterol
1970 StandoutNobel
Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis
2005
Invasive Candidiasis
2015 Standout
Global Comparison of the Membrane Subproteomes between a Multidrug-Resistant Acinetobacter baumannii Strain and a Reference Strain
2006
Contemporary Assessment of Antimicrobial Susceptibility Testing Methods for Polymyxin B and Colistin: Review of Available Interpretative Criteria and Quality Control Guidelines
2001
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Polymyxin antibiotics for gram-negative infections
2007
Investigating Cellular Metabolism of Synthetic Azidosugars with the Staudinger Ligation
2002 StandoutNobel
Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii : Molecular Basis for the Differential Mechanisms of Action
2006
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
2005
Epidemiologic and Molecular Characterization of an Outbreak of Candida parapsilosis Bloodstream Infections in a Community Hospital
2004
Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the OXA-23 Enzyme in Curitiba, Brazil
2003
Polymyxin B and Doxycycline Use in Patients with Multidrug-Resistant Acinetobacter baumannii Infections in the Intensive Care Unit
2006
Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria
2003
Antimicrobial Susceptibility Testing of Acinetobacter spp. by NCCLS Broth Microdilution and Disk Diffusion Methods
2004
Identification of a New Allelic Variant of theAcinetobacter baumanniiCephalosporinase, ADC-7 β-Lactamase: Defining a Unique Family of Class C Enzymes
2005
Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England
2006
The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review*
2015
Squalene synthetase activity in human fibroblasts: Regulation via the low density lipoprotein receptor
1979 StandoutNobel
In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
2004
Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods
2005
USA300 Genotype Community-Associated Methicillin-Resistant Staphylococcus aureus as a Cause of Surgical Site Infections
2007
Burn Wound Infections
2006 Standout
Molecular Mechanisms of Antibacterial Multidrug Resistance
2007
Circadian Rhythm of Gastric Acid Secretion in Man
1970 Nature
Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia
2006
INHIBITORS OF THE BIOSYNTHESIS AND PROCESSING OF N-LINKED OLIGOSACCHARIDE CHAINS
1987
Molecular Surveillance of European Quinolone-Resistant Clinical Isolates ofPseudomonas aeruginosaandAcinetobacterspp. Using Automated Ribotyping
2000
Synergistic Activity of Colistin and Ceftazidime against Multiantibiotic-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
2003
Species-Level Identification of Isolates of the Acinetobacter calcoaceticus - Acinetobacter baumannii Complex by Sequence Analysis of the 16S-23S rRNA Gene Spacer Region
2005
Probing to Bone in Infected Pedal Ulcers
1995
Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City
2003
Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus–baumannii complex in a Chinese hospital
2004
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
Squalene-2,3-Oxide, an Intermediate in the Enzymatic Conversion of Squalene to Lanosterol and Cholesterol
1967 StandoutNobel
Horizontal Transmission of Candida parapsilosis Candidemia in a Neonatal Intensive Care Unit
2002
Dolichol Monophosphate Glucose: An Intermediate in Glucose Transfer in Liver
1970 StandoutNobel
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
2003
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Characterization of a polyisoprenoid compound functional in O-antigen biosynthesis.
1967
Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii
2002
Loss of a 29-Kilodalton Outer Membrane Protein in Acinetobacter baumannii Is Associated with Imipenem Resistance
2002
The biosynthesis of cholesterol
1965
Works of Anna S. Levin being referenced
Candida parapsilosis candidaemia in a neonatal unit over 7 years: a case series study
2012
An Outbreak of Multiresistant Acinetobacter baumanii in a University Hospital in São Paulo, Brazil
1996
Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria
2015
Environmental Contamination by Multidrug-ResistantAcinetobacter baumanniiin an Intensive Care Unit
2001
Screening for renal disease using serum creatinine: who are we missing?
2001
Candida parapsilosis Fungemia Associated with Implantable and Semi-Implantable Central Venous Catheters and the Hands of Healthcare Workers
1998
Investigation of the possible association between nosocomial candiduria and candidaemia
2006
Evaluation of interventions to reduce catheter-associated bloodstream infection: Continuous tailored education versus one basic lecture
2010
Prevalence of cardiovascular damage in early renal disease
2001
Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam
2002
Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients
2010
Use of Ampicillin/Sulbactam Versus Imipenem/Cilastatin in the Treatment of Limb-Threatening Foot Infections in Diabetic Patients
1994
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem
2002
Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii
1999
Outer-membrane proteins pattern and detection of β-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil
2000
Treatment of Acinetobacter spp. infections
2003
Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B
2007
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis
2013
Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa
1999
Impact of an educational program and policy changes on decreasing catheter-associated bloodstream infections in a medical intensive care unit in Brazil
2005
Emergence of Resistance in Pseudomonas aeruginosa and Acinetobacter Species After the Use of Antimicrobials for Burned Patients
2004
Outbreak of Extended Spectrum β-Lactamase-Producing Klebsiella pneumoniae Infection in a Neonatal Intensive Care Unit Related to Onychomycosis in a Health Care Worker
2005
Infections in a burn intensive care unit: experience of seven years
2003
Purification of Geranylgeranyl Pyrophosphate Synthetase from Micrococcus lysodeikticus
1964
An Outbreak of Multiresistant Acinetobacter baumanii in a University Hospital in São Paulo, Brazil
1996
Outbreak of carbapenem-resistant Klebsiella pneumoniae: two-year epidemiologic follow-up in a tertiary hospital
2013
Increase in the lipid intermediate pathway of protein glycosylation during hen oviduct differentiation.
1977
Prevalence of SCC mec Type IV in Nosocomial Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus
2005
Differences in gastric secretion in normal individuals and patients with peptic ulcer; their bearing on ulcer management.
1952